Research progress of berberine mediated photodynamic therapy
- PMID: 33747216
- PMCID: PMC7967931
- DOI: 10.3892/ol.2021.12620
Research progress of berberine mediated photodynamic therapy
Abstract
Berberine (BBR) is a plant secondary metabolite that has been used in photodynamic therapy (PDT) in the last few decades. The present review aimed to discuss the research progress of BBR-mediated photodynamic actions. The following key words were searched in several databases: 'Berberine' combined with 'photodynamic therapy', 'sonodynamic therapy (SDT)', 'ultraviolet', 'reactive oxygen' and 'singlet oxygen'. The results demonstrated that both type I and type II reactions participated in the photodynamic progression of BBR derivatives. In addition, the photochemical characteristics of BBR derivatives were affected by the polarity, pH and O2 content of solvents. DNA binding increases the lifespan of the photoexcited BBR state and generation of singlet oxygen (1O2). The chemical properties of substituents in different positions of the BBR skeleton are pivotal for its photochemical properties, particularly the methylenedioxy group at the C-2 and C-3 positions. BBR is a promising agent for mediating both PDT- and SDT-treated diseases, particularly in tumors. However, further studies are required to validate their biological effects. In addition, the molecular mechanisms underlying the antitumor effects of BBR-PDT remain unclear and warrant further investigation. The structural modification and targeted delivery of BBR have made it possible to broaden its applications; however, experimental verification is required. Overall, BBR acts as a sensitizer for PDT and has promising development prospects.
Keywords: berberine; photodynamic therapy; reactive oxygen species; target drug delivery.
Copyright: © An et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures




Similar articles
-
Berberine-photodynamic induced apoptosis by activating endoplasmic reticulum stress-autophagy pathway involving CHOP in human malignant melanoma cells.Biochem Biophys Res Commun. 2021 May 7;552:183-190. doi: 10.1016/j.bbrc.2021.02.147. Epub 2021 Mar 19. Biochem Biophys Res Commun. 2021. PMID: 33751936
-
Development of Berberine-Loaded Nanoparticles for Astrocytoma Cells Administration and Photodynamic Therapy Stimulation.Pharmaceutics. 2023 Mar 27;15(4):1078. doi: 10.3390/pharmaceutics15041078. Pharmaceutics. 2023. PMID: 37111564 Free PMC article.
-
Berberine-sonodynamic therapy induces autophagy and lipid unloading in macrophage.Cell Death Dis. 2017 Jan 19;8(1):e2558. doi: 10.1038/cddis.2016.354. Cell Death Dis. 2017. PMID: 28102849 Free PMC article.
-
Berberine a traditional Chinese drug repurposing: Its actions in inflammation-associated ulcerative colitis and cancer therapy.Front Immunol. 2022 Dec 6;13:1083788. doi: 10.3389/fimmu.2022.1083788. eCollection 2022. Front Immunol. 2022. PMID: 36561763 Free PMC article. Review.
-
Research progress on berberine with a special focus on its oral bioavailability.Fitoterapia. 2016 Mar;109:274-82. doi: 10.1016/j.fitote.2016.02.001. Epub 2016 Feb 2. Fitoterapia. 2016. PMID: 26851175 Review.
Cited by
-
Berberine mediated fluorescent gold nanoclusters in biomimetic erythrocyte ghosts as a nanocarrier for enhanced photodynamic treatment.RSC Adv. 2024 Jan 19;14(5):3321-3334. doi: 10.1039/d3ra08299g. eCollection 2024 Jan 17. RSC Adv. 2024. PMID: 38249664 Free PMC article.
-
Multi-Target Potential of Berberine as an Antineoplastic and Antimetastatic Agent: A Special Focus on Lung Cancer Treatment.Cells. 2022 Oct 31;11(21):3433. doi: 10.3390/cells11213433. Cells. 2022. PMID: 36359829 Free PMC article. Review.
-
Elucidating Berberine's Therapeutic and Photosensitizer Potential through Nanomedicine Tools.Pharmaceutics. 2023 Sep 5;15(9):2282. doi: 10.3390/pharmaceutics15092282. Pharmaceutics. 2023. PMID: 37765251 Free PMC article. Review.
-
In Vitro Cell Death Mechanisms Induced by Dicoma anomala Root Extract in Combination with ZnPcS4 Mediated-Photodynamic Therapy in A549 Lung Cancer Cells.Cells. 2022 Oct 19;11(20):3288. doi: 10.3390/cells11203288. Cells. 2022. PMID: 36291155 Free PMC article.
-
Diabetes and Cancer: Metabolic Association, Therapeutic Challenges, and the Role of Natural Products.Molecules. 2021 Apr 10;26(8):2179. doi: 10.3390/molecules26082179. Molecules. 2021. PMID: 33920079 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous